Virginia Kaklamani, Professor of Medicine at UT Health San Antonio shared on X:
“My take aways from sabcs24: anthra beneficial for RS>31; imlunestrant active as single agent unclear what combo data means; Pablo gives excellent benefit in triple pos breast cancer; please don’t use MRD; brca + breast cancer patients have benefit from Risk-Reducing Bilateral Mastectomy; and tons of important data on local therapy.”